I think it's main benefit is that it offers consistency and as far as I can see helps remove human error as it offers
"Simple user interface
Precise incubation time and consistent process designed to optimize cell yield and promote cell viability"
As far as I'm concerned it should never have been delayed 6/12 by the FDA.
I think it's main benefit is that it offers consistency and...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.65 |
Change
-0.050(1.85%) |
Mkt cap ! $183.5M | |||
| Open | High | Low | Value | Volume |
| $2.64 | $2.68 | $2.63 | $283.6K | 107.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2206 | $2.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.67 | 5477 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |